United Kingdom · What does Kester Capital invest in?
Kester Capital invests most often at Series B (100% of the rounds on record), in sectors such as Technology and Life Sciences.
Kester Capital highlights
- 01
1 rounds on record
- 02
Mostly Series B: 100% of its rounds
- 03
1 exits from the portfolio
What they do
A sector focused private equity fund with outstanding credentials and expertiseFrom their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- Up to $75M as they say
- Stages
- Series ASeries B
- Sectors
- TechnologyLife Sciences
- Based in
- London, United Kingdom
- Cold pitches
- Not accepted
The record
Every round we can evidence, newest first1 appearances
- 2006
1 round
- Dec
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
AMAdam MaidmentExecutive OfficeriFiling they signed
RCRobert Cameron CrockettExecutive OfficeriFiling they signed
We also hold 7 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$332Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Kester Capital LLP
- SEC number
- CRD 174588
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
Xanthus PharmaceuticalsBought by AntisomaUndisclosedMay 2008
An exit counts when it came after the firm's first round in the company. From historical deal records.